Olpasiran

Intervention3 papers1 finding

Outcomes

1

Lipoprotein

downin humans1

1 study

Olpasiran decreases lipoprotein in humans (>80-100%).
Review
Lipoprotein(a): Cardiovascular Risk and Emerging Targeted Therapies · American journal of cardiovascular drugs : drugs, devices, and other interventions · 31 Aug 2026

Lipoprotein →

Latest

3

Journal of Clinical LipidologyReview17 h

Efficacy and tolerability of targeted lipoprotein(a)-lowering therapies: A systematic review

Methodist DeBakey Cardiovascular JournalReview19 Sep

Targeting Lipoprotein(a): A New Era in Cardiovascular Disease Prevention

Atherosclerotic cardiovascular disease

American Journal of Cardiovascular DrugsReview1 Sep

Lipoprotein(a): Cardiovascular Risk and Emerging Targeted Therapies